Retropsoas Technologies

Retropsoas Technologies is a healthcare company based in Frontenac, Missouri. The company has developed the EARP Nerve Cuff Electrode, a new Class II device that has received FDA approval. It serves as a component of intraoperative nerve monitoring by transmitting electrical signals, used in conjunction with commercially available nerve monitoring systems, without stimulating or recording signals itself. The proximal standard connector interfaces with nerve monitoring equipment, while the distal nerve cuff electrode partially surrounds and contacts the target nerve root. It employs a bipolar configuration to limit current spread. Available in various inner diameters, it accommodates variability in patients' nerve root anatomical sizes.